- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03517241
Objective Assessment of Macular Function at Retinal and Cortical Levels
A Multimodal Approach Towards an Objective Assessment of Macular Function at Retinal and Cortical Levels
Research questions/hypotheses: About 15% of the population over 40 years of age are affected by diseases of the retina. Accurate measurement of the extent of visual field impairment is of highest importance for disease subtype diagnosis and severity classification. The current gold-standard approach for the assessment of macular sensitivity is microperimetry (MP) where the patient is asked to report whether or not visual stimuli presented at different positions within the visual field are detected. While this technique is a very straightforward approach and simple in its application, it is important to note that MP is psychophysical in nature and requires constantly high attentional performance of the patient throughout the examination period. As many patients suffering from retinal diseases are well over 65 years of age, they are unable to maintain such high levels of attention over longer periods and, thus, MP results may be biased. Retinotopic assessment using population receptive field (pRF) mapping based on functional magnetic resonance imaging (fMRI) offers an alternative by allowing for objective visual field testing, independent of patient performance. We have shown previously in healthy subjects that pRF allows for accurate detection of simulated central scotomata down to 2.35 degrees radius. Also, pilot data in patients with retinal scotomata showed strong correspondence between pRF and MP results, i.e. macular regions with reduced macular sensitivity and atrophy of outer retinal layers correlated well with pRF coverage maps showing reduced density of activated voxels. The aim of this project is to determine whether pRF mapping could serve as an alternative visual field testing method by: (1) assessing test-retest reproducibility of pRF and MP in clinical populations with stable retinal diseases (Stargardt disease, geographic atrophy) over a four-week period; (2) assessing visual field changes over a one-year period in patients suffering from acute retinal scotomata (branch retinal artery occlusions, full-thickness macular holes). All pRF mapping will be accompanied by MP measurements to allow for a direct comparison of the two techniques.
Scientific/scholarly innovation/originality of the project: The present project applies a novel approach for linking retinal function assessed with MP and pRF mapping in a representative patient population with acute and chronic retinal diseases. The project seeks to contribute to best practice methods for using fMRI to assess macular dysfunction both for documentation of the natural course of the disease and during therapy in a study setting.
Methods: fMRI uses pRF mapping to provide retinotopic data (pRF coverage maps) that are then correlated with the results of conventional ophthalmic testing including MP, visual acuity and contrast sensitivity testing, reading performance, optical coherence tomography and autofluorescence imaging.
Study Overview
Status
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Markus Ritter, MD
- Phone Number: +4314040079400
- Email: markus.ritter@meduniwien.ac.at
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 20 patients clinically diagnosed with GA secondary to AMD.
- 20 patients clinically and genetically diagnosed with STGD.
- 20 patients clinically diagnosed with BRAO.
- 20 patients clinically diagnosed with acute FTMH before and after macular surgery.
- 20 healthy control subjects. Visual acuity of 20/16- 20/32
Exclusion Criteria:
- Presence of any other ophthalmological or neurological disease affecting visual function
- Cataract > grade 2 (according to lens opacities system)
- All routine exclusion criteria that apply to MRI scans including pacemakers, metallic implants, prostheses or coils, claustrophobia
- Pregnancy
- Dyslexia
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Geographic atrophy secondary to AMD
20 patients clinically diagnosed with geographic atrophy (GA) secondary to AMD.
|
Optical Coherence Tomography (OCT) is a non-invasive diagnostic technique that renders an in vivo cross sectional view of the retina.
Retinotopic mapping using functional magnetic resonance imaging (fMRI) is based on MR images acquired with blood-oxygenation-level-dependent (BOLD) contrast to reveal areas of neuronal activity in the visual cortex
MP allows localized testing of retinal sensitivity of foveal, parafoveal and even more peripheral macular regions
Fundus autofluorescence imaging (FAF), is a non-invasive diagnostic technique focusing on the fluorescent properties of pigments in the retina to generate images.
Best-corrected visual acuity will be measured using Early Treatment Diabetic Retinopathy Study (ETDRS) charts.
Reading acuity and reading speed will be examined using Radner Reading Charts.
Reading acuity is measured in logRAD unit (= reading equivalent of logMAR) and in critical font size (critical reading size), reading speed is measured in words per minute (wpm).
Contrast sensitivity will be determined using Pelli-Robson contrast sensitivity charts.
|
Stargards disease
20 patients clinically and genetically diagnosed with Stargards disease (STGD)
|
Optical Coherence Tomography (OCT) is a non-invasive diagnostic technique that renders an in vivo cross sectional view of the retina.
Retinotopic mapping using functional magnetic resonance imaging (fMRI) is based on MR images acquired with blood-oxygenation-level-dependent (BOLD) contrast to reveal areas of neuronal activity in the visual cortex
MP allows localized testing of retinal sensitivity of foveal, parafoveal and even more peripheral macular regions
Fundus autofluorescence imaging (FAF), is a non-invasive diagnostic technique focusing on the fluorescent properties of pigments in the retina to generate images.
Best-corrected visual acuity will be measured using Early Treatment Diabetic Retinopathy Study (ETDRS) charts.
Reading acuity and reading speed will be examined using Radner Reading Charts.
Reading acuity is measured in logRAD unit (= reading equivalent of logMAR) and in critical font size (critical reading size), reading speed is measured in words per minute (wpm).
Contrast sensitivity will be determined using Pelli-Robson contrast sensitivity charts.
|
Branch retinal artery occlusion
20 patients clinically diagnosed with branch retinal artery occlusion (BRAO)
|
Optical Coherence Tomography (OCT) is a non-invasive diagnostic technique that renders an in vivo cross sectional view of the retina.
Retinotopic mapping using functional magnetic resonance imaging (fMRI) is based on MR images acquired with blood-oxygenation-level-dependent (BOLD) contrast to reveal areas of neuronal activity in the visual cortex
MP allows localized testing of retinal sensitivity of foveal, parafoveal and even more peripheral macular regions
Fundus autofluorescence imaging (FAF), is a non-invasive diagnostic technique focusing on the fluorescent properties of pigments in the retina to generate images.
Best-corrected visual acuity will be measured using Early Treatment Diabetic Retinopathy Study (ETDRS) charts.
Reading acuity and reading speed will be examined using Radner Reading Charts.
Reading acuity is measured in logRAD unit (= reading equivalent of logMAR) and in critical font size (critical reading size), reading speed is measured in words per minute (wpm).
Contrast sensitivity will be determined using Pelli-Robson contrast sensitivity charts.
|
Full thickness macular hole
20 patients clinically diagnosed with acute full thickness macular hole (FTMH) before and after macular surgery
|
Optical Coherence Tomography (OCT) is a non-invasive diagnostic technique that renders an in vivo cross sectional view of the retina.
Retinotopic mapping using functional magnetic resonance imaging (fMRI) is based on MR images acquired with blood-oxygenation-level-dependent (BOLD) contrast to reveal areas of neuronal activity in the visual cortex
MP allows localized testing of retinal sensitivity of foveal, parafoveal and even more peripheral macular regions
Fundus autofluorescence imaging (FAF), is a non-invasive diagnostic technique focusing on the fluorescent properties of pigments in the retina to generate images.
Best-corrected visual acuity will be measured using Early Treatment Diabetic Retinopathy Study (ETDRS) charts.
Reading acuity and reading speed will be examined using Radner Reading Charts.
Reading acuity is measured in logRAD unit (= reading equivalent of logMAR) and in critical font size (critical reading size), reading speed is measured in words per minute (wpm).
Contrast sensitivity will be determined using Pelli-Robson contrast sensitivity charts.
|
Healthy controls
20 healthy control subjects.
Visual acuity of 20/16- 20/32
|
Optical Coherence Tomography (OCT) is a non-invasive diagnostic technique that renders an in vivo cross sectional view of the retina.
Retinotopic mapping using functional magnetic resonance imaging (fMRI) is based on MR images acquired with blood-oxygenation-level-dependent (BOLD) contrast to reveal areas of neuronal activity in the visual cortex
MP allows localized testing of retinal sensitivity of foveal, parafoveal and even more peripheral macular regions
Fundus autofluorescence imaging (FAF), is a non-invasive diagnostic technique focusing on the fluorescent properties of pigments in the retina to generate images.
Best-corrected visual acuity will be measured using Early Treatment Diabetic Retinopathy Study (ETDRS) charts.
Reading acuity and reading speed will be examined using Radner Reading Charts.
Reading acuity is measured in logRAD unit (= reading equivalent of logMAR) and in critical font size (critical reading size), reading speed is measured in words per minute (wpm).
Contrast sensitivity will be determined using Pelli-Robson contrast sensitivity charts.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correspondence between coverage maps originating from microperimetry and population-receptive field mapping of the primary visual cortex measured by functional magnetic resonance imaging.
Time Frame: 2 years
|
Qualitative and quantitative assessment of the correspondence between conventional functional assessment of retinal scotomata (microperimetry) and population-receptive field (pRF) mapping of the primary visual cortex measured by functional magnetic resonance imaging in patients clinically diagnosed with geographic atrophy secondary to age-related macular degeneration, Stargardts disease, branch retinal artery occlusions and full thickness macular holes before and after macular surgery.
The microperimetry test grid (retinal sensitivity measured in Decibel, dB) willl be correlated with the pRF coverage maps calculated from fMRI data.
Each dot represents the centre of a receptive field of a single voxel and every pRF centre is associated with a 2D Gaussian which together constitute the coverage map.
Correspondence between coverage maps will be quantified by calculating the matching coefficient.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correspondence between coverage maps originating from structural imaging (optical coherence tomography and autofluorescence imaging) and population-receptive field mapping of the primary visual cortex measured by functional magnetic resonance imaging.
Time Frame: 2 years
|
Qualitative and quantitative assessment of the correspondence between conventional structural assessment of retinal scotomata (optical coherence tomography and autofluorescence imaging) and population-receptive field (pRF) mapping of the primary visual cortex measured by functional magnetic resonance imaging in patients clinically diagnosed with geographic atrophy secondary to age-related macular degeneration, Stargardts disease, branch retinal artery occlusions and full thickness macular holes before and after macular surgery.
The retinal layer thickness maps (measured in micometer, µm) willl be correlated with the pRF coverage maps calculated from fMRI data.
Each dot represents the centre of a receptive field of a single voxel and every pRF centre is associated with a 2D Gaussian which together constitute the coverage map.Correspondence between coverage maps will be quantified by calculating the matching coefficient.
|
2 years
|
Reproducibility assessment
Time Frame: 1 year
|
Reproducibility of population-receptive field mapping of the primary visual cortex and of conventional ophthalmic assessment (microperimetry, visual acuity and contrast sensitivity testing, reading performance, optical coherence tomography and autofluorescence imaging) in patients with retinal scotomata secondary to Stargardt disease and geographic atrophy compared with normal control participants with artificial scotomata.
|
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK1816/2014
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retina Disorder
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Sun Yat-sen UniversityRecruiting
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
The Second People's Hospital of FoshanRecruiting
-
Masaryk Hospital Usti nad LabemCompleted
-
The Second People's Hospital of FoshanNot yet recruiting
-
Shaare Zedek Medical CenterUnknownRetina, Choroid, Sclera
-
Sun Yat-sen UniversityCompletedNormal Eyes | Peripheral RetinaChina
-
University of OxfordCompletedRetina; ChangeUnited Kingdom
-
Zilia Inc.CHU de Quebec-Universite LavalTerminatedRetinal Vascular | RetinaCanada
Clinical Trials on Optical coherence tomography (OCT)
-
China National Center for Cardiovascular DiseasesBeijing Tongren HospitalNot yet recruiting
-
Azienda Ospedaliera Città della Salute e della...Recruiting
-
Norfolk and Norwich University Hospitals NHS Foundation...Completed
-
Vanderbilt University Medical CenterEnrolling by invitationHealthy VolunteersUnited States
-
University Hospital, Clermont-FerrandAbbott; Corelab ISITCompletedIn-stent RestenosisFrance, Belgium, Switzerland
-
University of NottinghamCompletedRetinal ImagingUnited Kingdom
-
Catholic University of the Sacred HeartCompleted
-
Dr. S.S. Michel ClinicCompletedTomography, Optical CoherenceCanada
-
Dr. S.S. Michel ClinicCompletedDiagnoses Disease | Pituitary MassCanada
-
University of PalermoRecruitingOral Disease | Oral Cancer | Actinic Keratoses | Oral Leukoplakia | Oral Squamous Cell Carcinoma | Oral Lichen Planus | Graft-versus-host-disease | Proliferative Verrucous Leukoplakia | Actinic Cheilitis | Oral Potentially Malignant Disorder | Oral Erythroplakia | Oral Lichenoid LesionItaly